Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Paris

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Microbiology|April 26, 2013
Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective studyH Fricker-Hidalgo, B Cimon, C Chemla, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonistsKenneth M Meyers, José Méndez-Andino, Anny-Odile Colson, et al.
The Journal of Urology|September 25, 2017
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical ProstatectomyHao G Nguyen, Christopher Welty, Karla Lindquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysisHerman van Dekken, Pamela L Paris, Donna G Albertson, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Creating class I MHC-null pigs using guide RNA and the Cas9 endonucleaseLuz M Reyes, Jose L Estrada, Zheng Yu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agentsNamal C Warshakoon, Justin Sheville, Ritu Tiku Bhatt, et al.
BMC Cancer|September 24, 2016
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patientsArchana Anantharaman, Terence Friedlander, David Lu, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Microbiology|April 26, 2013
Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective studyH Fricker-Hidalgo, B Cimon, C Chemla, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonistsKenneth M Meyers, José Méndez-Andino, Anny-Odile Colson, et al.
The Journal of Urology|September 25, 2017
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical ProstatectomyHao G Nguyen, Christopher Welty, Karla Lindquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysisHerman van Dekken, Pamela L Paris, Donna G Albertson, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Creating class I MHC-null pigs using guide RNA and the Cas9 endonucleaseLuz M Reyes, Jose L Estrada, Zheng Yu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agentsNamal C Warshakoon, Justin Sheville, Ritu Tiku Bhatt, et al.
BMC Cancer|September 24, 2016
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patientsArchana Anantharaman, Terence Friedlander, David Lu, et al.
Pageof 29